CD8A and cancer: Abnormal levels of NK cell, CD8+ T cells, memory CD4+/CD4+, naïve CD4+/CD4+, CD8+ HLA‐DR/CD8+, CD8+CD38+/CD8+, and CD4+/CD8+ can be a potential blood biomarkers of cancer disease progression.